HDAC inhibitor Entinostat, Purity ≥98%

Cat. No.: X23-10-ZQ302

HDAC inhibitor Entinostat, Purity ≥98%

Synonym: 209783-80-2; Entinostat; ms-275; SNDX-275; Entinostat (MS-275); MS 275; HDAC inhibitor

  • MDL: MFCD08272435
  • CAS Number: 209783-80-2
  • Compound CID: 4261
Product Size
10 mg; 25 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Entinostat, soluble in DMSO and insoluble in ethanol and water, induces DNA damage and the inhibition of DNA repair processes. It targets HDAC1 and HDAC3.
Molecular Weight
376.4
Molecular Formula
C21H20N4O3
Targets
HDAC1: 0.51 μM; HDAC3: 1.7 μM
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 71 mg/mL (188.62 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Entinostat is investigated for its role in inhibiting HDACs, particularly in enhancing anticancer immune responses and sensitivity to other treatments.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.